Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
aztreonam (azactam) (1 trial)
cefepime (maxipeme) (1 trial)
ceftazidime (fortaz) (1 trial)
ceftriaxone (rocephin) (1 trial)
cefuroxime (zinacef) (1 trial)
ciprofloxacin (cipro) (1 trial)
clavulanate (Augmentin) (1 trial)
daptomycin (cubicin) (1 trial)
ertapenem (invanz) (1 trial)
fosfomycin (monurol) (2 trials)
imipenem (primaxin) (1 trial)
inactivated influenza vaccine (1 trial)
isoniazid (nydrazid) (1 trial)
levofloxacin (levaquin) (1 trial)
meropenem (merrem) (3 trials)
piperacillin (pipracil) (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
sulfamethoxazole (gantanol) (1 trial)
tazobactam (Zosyn) (1 trial)
temocillin (1 trial)
trimethoprim (1 trial)
Bacteremia (Phase 3)
Communicable Diseases (Phase 3)
Enterobacteriaceae Infections (Phase 3)
Infections (Phase 3)
Influenza, Human (Phase 3)
Latent Tuberculosis (Phase 3)
Tuberculosis (Phase 3)
Trials (6 total)
Trial APIs (21 total)